报价延迟最少15分钟:2026/05/12 21:51 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.68 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.23/-0.30
|
|
企业价值
50.26M
|
| 资产负债 |
|
每股账面净值
-0.15
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
241.00K
|
|
每股收益
0.00
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing. |
